Поисковый запрос: (<.>S=TPS<.>) |
Общее количество найденных документов : 54
Показаны документы с 1 по 20
|
|
1.
| Blazquez Miguel A. Use of Yarrowia lipolytica hexokinase for the quantitative determination of trehalose 6-phosphate // FEMS Microbiol. Lett., 1994. Vol. 121, N 2.-С.223-228
|
2.
| Van Dalen A. Significance of cytokeratin markers TPA, TPA (cyk), TPS and CYFRA 21.1 in metastatic disease // Anticancer Res., 1996. Vol. 16, N 4b.-С.2345-2350
|
3.
| Van Dalen A. Significance of cytokeratin markers TPA, TPA (cyk), TPS and CYFRA 21.1 in metastatic disease // Anticancer Res., 1996. Vol. 16, N 4b.-С.2345-2350
|
4.
| Bremer Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer // Anticancer Res., 1996. Vol. 16, N 2.-С.905-909
|
5.
| Bremer Notable relationship between the level of tumor marker TPS in serum and survival in breast cancer // Anticancer Res., 1996. Vol. 16, N 2.-С.905-909
|
6.
| TPS-prognosticator in breast cancer // Anticancer Res., 1998. Vol. 18, N 6c.-С.4982
|
7.
| The significance of increasing marker levels (TPS, CA 15-3, CEA) in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease during therapy monitoring // Anticancer Res., 1998. Vol. 18, N 6c.-С.4856
|
8.
| The significance of increasing marker levels (TPS, CA 15-3, CEA) in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease during therapy monitoring // Anticancer Res., 1998. Vol. 18, N 6c.-С.4856
|
9.
| The significance of increasing marker levels (TPS, CA 15-3, CEA) in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease during therapy monitoring // Anticancer Res., 1998. Vol. 18, N 6c.-С.4856
|
10.
| Zaragoza Disruption of the Candida albicans TPS1 gene encoding trehalose-6-phosphate synthase impairs formation of hyphae and decreases infectivity // J. Bacteriol., 1998. Vol. 180, N 15.-С.3809-3815
|
11.
| Serial TPS and PSA determinations in monitoring hormone treated prostate cancer // Anticancer Res., 1998. Vol. 18, N 6c.-С.4998
|
12.
| Serum TPS value and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy and as a probe used in staging protocols (Stage D2 to D3 cancer) // Anticancer Res., 1998. Vol. 18, N 6c.-С.4957
|
13.
| Serial TPS and PSA determinations in monitoring hormone treated prostate cancer // Anticancer Res., 1998. Vol. 18, N 6c.-С.4998
|
14.
| Serum TPS value and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy and as a probe used in staging protocols (Stage D2 to D3 cancer) // Anticancer Res., 1998. Vol. 18, N 6c.-С.4957
|
15.
| Serum TPS value and a bone scan in estimating the rate of apoptosis in prostate cancer responders to therapy and as a probe used in staging protocols (Stage D2 to D3 cancer) // Anticancer Res., 1998. Vol. 18, N 6c.-С.4957
|
16.
| Zaragoza Disruption of the Candida albicans TPS1 gene encoding trehalose-6-phosphate synthase impairs formation of hyphae and decreases infectivity // J. Bacteriol., 1998. Vol. 180, N 15.-С.3809-3815
|
17.
| Serum markers for monitoring of prostatic carcinoma // Prostate, 1997. Vol. 33, N 3.-С.208-216
|
18.
| Serum markers for monitoring of prostatic carcinoma // Prostate, 1997. Vol. 33, N 3.-С.208-216
|
19.
| Serum markers for monitoring of prostatic carcinoma // Prostate, 1997. Vol. 33, N 3.-С.208-216
|
20.
| Serum markers for monitoring of prostatic carcinoma // Prostate, 1997. Vol. 33, N 3.-С.208-216
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"